1. What is Sermorelin?

Sermorelin (GRF 1–29) is a synthetic peptide fragment corresponding to the first 29 amino acids of growth hormone-releasing hormone (GHRH). It has been investigated in research for its role in endocrine signaling and regulation of growth hormone pathways. Scientific studies focus on its ability to engage pituitary GHRH receptors and to serve as a tool in exploring age-related changes in growth hormone axis biology.

2. Sermorelin Structure

Sequence:Tyr-DL-Ala-DL-Asp-DL-Ala-DL-xille-DL-Phe-DL-xiThr-DL-Asn-DL-Ser-DL-TyrDL-Arg-DL-LyS-DL-Val-DL-Leu-GIy-DL-GIn-DL-Leu-DL-Ser-DL-Ala-DL-Arg-DL-LyS-DLLeu-DL-Leu-DL-GIn-DL-Asp-DL-xille-DL-Met-DL-Ser-DL-Arg

Molecular Formula: C₁₄₉H₂₄₆N₄₄O₄₂S

Molecular Weight: 3357.933 g/mol

PubChem ClD: 16129620

3. Sermorelin Research

Sermorelin has been studied as a truncated analog of GHRH, retaining the bioactive domain responsible for receptor engagement in the pituitary.

l  Molecular Mechanisms: Research shows it can bind GHRH receptors and stimulate downstream cAMP pathways in experimental models 【1】.

l  Endocrine Axis Studies: Reports describe modulation of insulin-like growth factor (IGF-1) levels in preclinical and observational studies 【2】.

l  Neuroendocrine Implications: Sermorelin has been explored as a probe for understanding age-related growth hormone decline, pituitary responsiveness, and circadian hormonal regulatio【3】.

⚠️ Note: All data are limited to experimental and early-phase research contexts; results cannot be extrapolated to clinical efficacy or safety.

Why Consider Sermorelin?

l  Growth hormone biology: Model peptide for studying pulsatile GH release in research.

l  IGF-1 regulation: Explored for its effects on downstream IGF-1 signaling in laboratory contexts.

l  Endocrine modulation: Useful in understanding pituitary receptor function and somatostatin feedback.

l  Aging studies: Considered in models of age-associated decline in GH/IGF-1 activity.

l  Transcriptomic and metabolic impact: Ongoing research into systemic signaling and metabolic adaptation.

4. Future Sermorelin  Research

·  Comparative models: Evaluate Sermorelin versus other GHRH analogs in endocrine research.

·  Age-related decline: Study applications in understanding endocrine senescence and longevity biology.

·  Mechanistic deep-dive: RNA-seq and proteomic mapping to identify Sermorelin-responsive gene networks.

·  Combination studies: Potential synergy with peptides such as epitalon, NAD⁺ precursors, or metabolic regulators (only in preclinical systems).

5. Application Areas

l  Endocrine research: Models of GH/IGF-1 pathway regulation.

l  Aging biology: Investigating hormonal decline and circadian rhythm modulation.

l  Metabolic studies: Exploring endocrine effects on glucose, lipid, and energy pathways.

l  Neuroendocrinology: Research into pituitary responsiveness and hypothalamic-pituitary signaling.

✅ Summary

Sermorelin is a truncated GHRH analog studied as a research tool for understanding growth hormone regulation, IGF-1 signaling, and age-related endocrine changes. Its short half-life and preserved receptor-binding function make it valuable for preclinical and mechanistic research into hormone biology and metabolic regulation.

⚠ Disclaimer

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products offered on this website are furnished for in-vitro studies only. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.